Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

ABSTRACT: The expanding legalization of cannabis across the United States is associated with increases in cannabis use, and accordingly, an increase in the number and severity of individuals with cannabis use disorder (CUD). The lack of FDA-approved pharmacotherapies and modest efficacy of psychotherapeutic interventions means that many of those who seek treatment for CUD relapse within the first few months. Consequently, there is a pressing need for innovative, evidence-based treatment development for CUD. Preliminary evidence suggests that repetitive transcranial magnetic stimulation (rTMS) may be a novel, non-invasive therapeutic neuromodulation tool for the treatment of a variety of substance use disorders (SUDs), including recently receiving FDA clearance (August 2020) for use as a smoking cess

SUBMITTER: Kearney-Ramos T 

PROVIDER: S-EPMC9165758 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature